Nephros Management
Management criteria checks 4/4
Nephros' CEO is Robert Banks, appointed in May 2023, has a tenure of 2.58 years. total yearly compensation is $410.17K, comprised of 85.3% salary and 14.7% bonuses, including company stock and options. directly owns 0.66% of the company’s shares, worth $366.10K. The average tenure of the management team and the board of directors is 2.9 years and 3.3 years respectively.
Key information
Robert Banks
Chief executive officer
US$410.2k
Total compensation
| CEO salary percentage | 85.33% |
| CEO tenure | 2.6yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2.9yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Nephros (NASDAQ:NEPH) Is Experiencing Growth In Returns On Capital
Dec 13
Why Investors Shouldn't Be Surprised By Nephros, Inc.'s (NASDAQ:NEPH) 27% Share Price Surge
Oct 01At US$4.26, Is Nephros, Inc. (NASDAQ:NEPH) Worth Looking At Closely?
Sep 13It's Down 26% But Nephros, Inc. (NASDAQ:NEPH) Could Be Riskier Than It Looks
Aug 07Nephros, Inc.'s (NASDAQ:NEPH) 79% Jump Shows Its Popularity With Investors
Jun 16Should You Think About Buying Nephros, Inc. (NASDAQ:NEPH) Now?
May 14Investors Still Aren't Entirely Convinced By Nephros, Inc.'s (NASDAQ:NEPH) Revenues Despite 32% Price Jump
Apr 18It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)
Oct 03We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn
Jul 14Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates
May 13After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar
Dec 18At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?
Dec 14Nephros partners with Donastar and Tractor Beverage to supply and service nationwide fast-casual restaurant operation
Sep 28US$5.13: That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After Its Latest Results
Aug 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | US$1m |
| Jun 30 2025 | n/a | n/a | US$1m |
| Mar 31 2025 | n/a | n/a | US$801k |
| Dec 31 2024 | US$410k | US$350k | US$74k |
| Sep 30 2024 | n/a | n/a | -US$929k |
| Jun 30 2024 | n/a | n/a | -US$1m |
| Mar 31 2024 | n/a | n/a | -US$1m |
| Dec 31 2023 | US$824k | US$229k | -US$2m |
Compensation vs Market: Robert's total compensation ($USD410.17K) is about average for companies of similar size in the US market ($USD577.67K).
Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.
CEO
Robert Banks (50 yo)
Mr. Robert Banks is President, Director & CEO of Nephros, Inc. from May 2023. Mr. Banks has a proven track record of delivering value through innovation and aligning the strengths of his organizations with...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.6yrs | US$410.17k | 0.66% $ 366.1k | |
| Chief Financial Officer | 2.1yrs | US$148.70k | 0% $ 0 | |
| Director of Brand | 2.9yrs | no data | no data | |
| Vice President of Quality | 3.9yrs | no data | no data | |
| President of Aether Water Systems | 5.2yrs | no data | no data | |
| Controller | 2.9yrs | no data | no data |
Experienced Management: NEPH's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.6yrs | US$410.17k | 0.66% $ 366.1k | |
| Director | 18.3yrs | US$49.48k | 1.24% $ 686.6k | |
| Independent Director | 7.3yrs | US$65.39k | 1.16% $ 642.7k | |
| Independent Director | 3.3yrs | US$45.52k | 0.17% $ 92.5k | |
| Director | less than a year | no data | 0.015% $ 8.5k |
Experienced Board: NEPH's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/24 23:00 |
| End of Day Share Price | 2025/12/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nephros, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Wasserman | Benchmark Company |
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Anthony Vendetti | Maxim Group |